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ABSTRACT
Background: Receptor-interacting protein (RIP)-2 is a serinethreonine kinase containing a caspase recruit-
ment domain (CARD) that is involved in the Toll-like receptor-signaling pathway. Although associations be-
tween endotoxin exposure or respiratory infection and asthma have been recognized, the genetic influences in
these conditions are unclear. The aim of our study was to examine whether polymorphisms or haplotypes in
RIP2 were associated with childhood atopic asthma in a Japanese population．
Methods:We screened the RIP2 gene for polymorphisms by direct sequencing and characterized the linkage
disequilibrium (LD) mapping of the gene. Seven variants were genotyped in childhood atopic asthma ( n = 300)
and normal controls ( n = 637) . We conducted case-control and case-only association studies between the
variants and asthma-related phenotypes. Haplotype association analyses were also performed．
Results: A total of 31 variants were identified and none of the alleles or haplotypes of RIP2 were associated
with asthma susceptibility. In the case-only study, an association between an RIP2 promoter polymorphism and
childhood severe asthma ( P=0.0032;odds ratio (OR) 3.37, 95% confidence interval (CI) 1.45―7.87) was ob-
served．
Conclusions: Although polymorphisms in RIP2 are not likely to be associated with the development of
asthma, the genetic variants might contribute to asthma severity in the Japanese population．
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INTRODUCTION
Asthma is defined as a chronic inflammatory lung dis-
ease characterized by airway hyperreactivity and mu-
cus hypersecretion that results in intermittent airway
obstruction.1 Clinical and experimental evidence sug-
gest that respiratory infections play an important role
in the development of asthma.2,3 Toll-like receptors
(TLRs) play an essential role in activation of the in-
nate immune system, which in turn activates adaptive
immunity . 4,5 The association between polymor-
phisms in TLR genes and asthma has been inten-
sively studied.6,7 Immunization with an antigen in the
context of TLR2 ligands can result in experimental
asthma8 and genetic variation in TLR2 is a major fac-
tor in the susceptibility to asthma in children of farm-
ers.9 Viral infections are thought to be an important
factor influencing both the development and the se-
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Fig. 1 Genomic structure and linkage disequilibrium at RIP2. Pairwise linkage disequilibrium (LD) was measured by 
|D’| and r2 among the 28 SNPs studied in 12 sequenced samples.
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verity of asthma.10,11 TLR3 functions as a receptor for
double-stranded RNA (dsRNA), a molecular pattern
produced by most viruses at some point in the infec-
tion cycle, and dsRNA is a potent inducer of inter-
feron and an activator of the interferon-induced antivi-
ral molecules.12,13 TLR4 is an essential receptor for
the recognition of endotoxin derived from gram-
negative bacteria.4,5 Recent studies showed that the
immune response induced by endotoxin could play
an important role in the initiation or prevention of
asthma.14,15 Although no association was observed
between TLR 4 polymorphism and the risk of
asthma,16 Yang et al.17 have shown that TLR4 gene
variants modify endotoxin effects on asthma and re-
late to the severity of asthma. RIP2 is required for
production of the inflammatory cytokines through
TLR-2, -3, and -4 signaling.18
Many cytokines are involved in the development of
the chronic inflammation of asthma.19 In an animal
model, requirements for RIP2 in multiple pathways
regulating immune and inflammatory responses were
reported. RIP2 deficiency results in impaired inter-
feron (IFN)-γ production in Th1 and natural killer
cells due to a defective interleukin (IL) -12-induced
signal transducer and activator of transcription (Stat)
4 activation.20 It is possible that the polymorphisms
of RIP 2 result in inappropriate inflammatory re-
sponses through altered IFN-γ production．
Given the contributions of respiratory infections
and cytokines in asthma, it seems probable that de-
regulation of the normal RIP2 function could promote
disease. To test whether variants of RIP2 were re-
lated to asthma , we first carried out linkage dise-
quilibrium mapping of the gene, and conducted an as-
sociation study and haplotype analyses with regard to
the LD pattern.
METHODS
STUDY SUBJECTS
All subjects with asthma were diagnosed according to
the criteria of the National Institutes of Health (Na-
tional Heart, Lung, and Blood Institute, National Insti-
tutes of Health, 1991)21 and demonstrated at least
12% improvement in their FEV1 measurement after β2
-agonist inhalation. The diagnosis of atopic asthma
was based on one or more positive skin scratch test
responses to seven common aeroallergens in the
presence of a positive histamine control and a nega-
tive vehicle control . The seven aeroallergens were
house dust, Felis domesticus, dander (Feld),Canis fa-
miliaris dander, Dactylis glomerata, Ambrosia, Cryp-
tomeria japonica and Alternaria alternata. Peripheral
blood was obtained from each of the 300 pediatric
atopic asthma outpatients at the Osaka Prefectural
Habikino Hospital and National Sagamihara Hospital
(mean age 9.9, 4―15 years;male:female ratio=1.53:1.0;
Dermatophagiodes pteronyssinus or Derma-
tophagiodes farinae RAST positive 89.0%). The serum
IgE level was log10-transformed before analysis. The
mean of log10[total IgE (tIgE)(IUml)]of patients
with childhood atopic asthma was 2.68 [= log10(479
IUml)].In this study,“high IgE”levels were defined
as those values in the 75th percentile or higher for to-
tal IgE and the severity of asthma was defined accord-
ing to the degree of therapy required to control symp-
toms at the time of entry into the study. The grades
were as follows:grade 1, β agonists only;grade 2, so-
dium cromoglycate andor theophylline;grade 3, in-
haled beclomethasone, 400 μgday or less;grade 4,
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Table 1 Polymorphisms in RIP2 Genes
NCBI¶
dbSNP
JSNP ID§ 
IMS-JST
Minor alele 
frequency (%)
Amino acidPosition‡NucleotideLocationSNP†
22938070470710.08-980T/G5’ genomeSNP 1†
22938080470720.17-933G/A5’ genomeSNP 2†
58931100.42-491wt/GCCTCTGGC5’ genomeSNP 3
22938090470730.17Ala9Ala26C/Texon 1SNP 4
0.33304A/Gintron 1SNP 5
22675400209940.332170A/Gintron 1SNP 6
38317110830360.332174wt/insAintron 1SNP 7
4028860209950.332212C/Tintron 1SNP 8
395000209960.292377G/Aintron 1SNP 9†
 395010209970.082478T/Cintron 1SNP 10†
0.047170T/Aintron 2SNP 11
4312640810840.337222G/Aintron 2SNP 12
169004840.0811644A/Cintron 3SNP 13
403771193020.2911665C/Tintron 3SNP 14† 
0.0813458C/Tintron 4SNP 15
0.08Ile259Thr14691T/Cexon 6SNP 16
0.0825916A/Gintron 7SNP 17
0.0825920T/Cintron 7SNP 18
0.0828685A/Tintron 9SNP 19
0.0828689wt/insCintron 9SNP 20
119950050.1728711A/Gintron 9SNP 21
0.0431179wt/insTintron 9SNP 22
402470810850.4631684C/Aintron 10SNP 23† 
404530.4231757A/Gintron 10SNP 24†
4004110.4231811A/Gintron 10SNP 25
0.08Leu491Leu32203A/Gexon 11SNP 26
169006270.0832707A/Gexon 11SNP 27
0.0832880AAAC/delexon 11SNP 28
169006400.0433541G/A3’ genomeSNP 29
0.0833562AT/del3’ genomeSNP 30
395090.4233877G/A3’ genomeSNP 31
†SNPs were genotyped in this study.
‡Numbering according to the genomic sequence of RIP2 (AF117829).
Position 1 is the A of the initiation codon.
§JSNP ID, Number from the Japanese SNP database (htp:/snp.ims.u-tokyo.ac.jp/)
¶NCBI, Number from the dbSNP of NCBI (htp:/www.ncbi.nlm.nih.gov/SNP/)
inhaled beclomethasone of more than 400 μgday.22
A total of 637 healthy individuals who had neither res-
piratory symptoms nor a history of asthma-related
diseases (mean age 47.2, 20―75 years;male:female ra-
tio = 2.82 :1.0) were recruited by physicians’ inter-
views pertaining to whether they had been diagnosed
with asthma andor atopy. All individuals were Japa-
nese and gave written informed consent to participate
in the study (or, for individuals less than 16 years old,
their parents gave consent),according to the rules of
the process committee at the SNP Research Center,
The Institute of Physical and Chemical Research
(RIKEN).
SCREENING FOR POLYMORPHISMS AND
GENOTYPING
To identify polymorphisms in the human RIP2 gene,
we sequenced all eleven exons, including a minimum
of 100 bases of the flanking intronic sequence, 1 kb of
the 5 ’ flanking region, and a 0.2 kb continuous 3 ’
flanking region of the 11th exon from 12 control sub-
jects. Fifteen primer sets were designed on the basis
of the RIP2 genomic sequence from the GenBank da-
tabase ( accession number AF 117829 ) . Those se-
quences were analyzed and polymorphisms were
identified using the SEQUENCHER program (Gene
Codes Corporation, Ann Arbor, MI, USA). For the -
980TG, -933 GA, 2377AG, 2478TC and 11665CT
Allergology International Vol 55, No1, 2006 www.jsaweb.jp 79
Rip2 Gene and Childhood Asthma
Table 2 Genotype Frequencies for RIP2 SNPs and Childhood Atopic Asthma Susceptibility
Atopic asthma (n＝300)Control (n＝637)SNP
Gene
§P＝‡P＝†P＝321321Location
NSNSNS0.0030.0810.9150.0000.0900.910SNP 1RIP2
NSNSNS0.0440.3120.6440.0410.3090.650SNP 2
NSNSNS0.1610.4900.3490.1580.4630.379SNP 9
NSNSNS0.0000.0940.9060.0030.1010.896SNP 10
NSNSNS0.1170.4980.3850.1200.4550.425SNP 14
NSNSNS0.1910.4900.3190.1830.4850.332SNP 23
NSNSNS0.1600.4760.3640.1650.4620.373SNP 24
NS, Not significant.
†Dominant model.
‡Recessive model.
§Codominant model.
Table 3 Association between SNPs and Asthma-related Phenotypes
Pχ2 (df＝1)OR (95% CI)GGTGTTRIP2 SNP1 (-980 T/G)
0.00328.693.37 (1.45―7.87)†0.0040.0560.940233Severity＝1, 2, 3
0.0000.1770.82362Severity＝4
†TT vs TG+GG.
Table 4 Haplotype Frequencies of Polymorphisms of the RIP2 Genes
Controls
(n＝637)
Child 
asthma
(n＝300)
SNP position
SNP 24SNP 23SNP 14SNP 10SNP 9SNP 2SNP 1
0.580.57AATTGAT1
0.200.20GCCTAGT2
0.100.11GCCTAAT3
0.040.04GCTTAAG4
0.050.04GCCCAAT5
0.030.03ACTTGAT6
0.000.00Others
polymorphisms , genotyping was performed by In-
vader assay as described . 23 The polymorphisms
31684CA and 31757AG were genotyped by use of
the TaqMan system ( Applied Biosystems , Foster
City, CA, USA).
STATISTICAL ANALYSIS
Pairwise linkage disequilibrium (LD) was calculated
as |D’| and r2 by using the SNP Alyze statistical pack-
age (Dynacom, Chiba, Japan) as described.24 We cal-
culated allele frequencies and tested agreement with
Hardy-Weinberg equilibrium using a χ2 goodness of
fit test at each locus. We then compared differences
in allele frequencies and the genotype distribution of
each polymorphism between case and control sub-
jects by using a 2 × 2 contingency χ2 test with one de-
gree of freedom, and calculated odds ratios (ORs)
with 95 percent confidence intervals (95% CI)．
Haplotype frequencies for multiple loci were esti-
mated using the expectation-maximization method
with SNP Alyze software.24 Haplotype frequencies in
cases and controls were evaluated both by the whole
distribution with Fisher’s exact test and by χ2 tests of
one haplotype against others (haplotype-wise test) . 22
We also examined haplotype frequencies and haplo-
type association using haploview software (http :
www.broad.mit.edumpghaploviewindex.php).
Because SNPs in each gene were in linkage dise-
quilibrium (Fig . 1) and asthma-related phenotypes
were significantly related, the simple multiplication of
P -values by the number of SNPs or phenotypes
tested is too conservative and the appropriate value
for the correction is not evident. Thus, to deal with
the multiple comparisons, we did not apply Bonfer-
roni corrections but rather set the significant P -
values at 0.01 rather than 0.05.22
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RESULTS
We carried out screening of polymorphisms with
genomic DNA from 12 randomly selected control in-
dividuals. After extensive examination of RIP2 by di-
rect sequencing, we identified 25 single nucleotide
polymorphisms ( SNPs ) and six insertion-deletion
polymorphisms in RIP2 ( Table 1 ). Nineteen poly-
morphisms were contained in the two available public
databases:NCBI dbSNP (http:www.ncbi.nlm.nih.
govSNP) and IMS-JST JSNP DATABASE (http:
snp.ims.u-tokyo.ac.jp）． A non-synonymous substi-
tution was found in RIP2 (Ile259Thr). To examine the
linkage disequilibrium ( LD ) between identified
SNPs, pairwise LD coefficients |D’| and r2 were calcu-
lated using the SNPAlyse program as described. Rare
SNPs with minor allele frequencies of 4% were not in-
cluded in the analysis. Most of these SNPs were lo-
cated in one extended block of LD and some were in
tight LD (Fig. 1) .We selected five SNPs with a fre-
quency >0.15 with regard to the LD pattern across
the gene . Furthermore , we genotyped a promoter
SNP, -980 TG, and intronic SNP, 2478 TC, that
were in strong linkage disequilibrium with another
non-synonymous variant , 14691 TC ( Ile 259 Thr )
( |D’| = 1.00 and r2 = 1.00).
All of these loci were in Hardy-Weinberg equilib-
rium in the control group. The allele frequency of
each selected polymorphism was compared between
the patients and the normal controls by the χ2 test us-
ing codominant , dominant , and recessive models .
The results of allele frequencies in the asthma group
and control group are shown in Table 2. There was
no significant association between any SNP of RIP2
and childhood atopic asthma patients ( Table 2 ).
In the case-only study , associations between
asthma-related phenotypes and SNPs of the RIP 2
gene were also investigated. We found a significant
association between SNP1 and the most severe cases
of childhood atopic asthma (OR = 3.37, 95%CI = 1.45―
7.87, χ2 = 8.69, P = 0.0032)(Table 3). There was no
significant association between any SNP of the RIP2
gene and asthma patients who had a high (>10%)
eosinophil count and high serum IgE level．
We further analyzed the haplotype structure using
seven SNPs (SNP1, SNP3, SNP9, SNP10, SNP13,
SNP21 and SNP22) and compared the frequencies of
the haplotypes between controls and childhood
atopic asthma ( Table 4 ). The estimated frequency
pattern of the haplotype using SNP Alyze or
haploview software did not differ between the control
and asthma groups.
DISCUSSION
In this study, we identified polymorphisms in RIP2,
and performed case-control and case-only association
studies as well as haplotype analyses using clinically
characterized asthma patients. We found SNP 14691
TC (Ile259Thr),resulting in non-synonymous amino
acid substitution and a variant located in the pre-
dicted serine threonine kinase domain of RIP2. Ko-
bayashi et al.18 demonstrated reduced inflammatory
cytokine production in response to the ligands for
TLR2, TLR3, TLR4 and TLR9 using RIP2-deficient
mice. The function of TLRs in various human dis-
eases has been investigated, and these studies have
shown that TLR function affects several diseases such
as sepsis, immunodeficiencies and atherosclerosis.6
Although we could not find any significant association
between the tested SNPs and asthma susceptibility,
the 259Thr variant might be associated with the etiol-
ogy of another disease through alteration of protein
function. Further studies are needed to evaluate the
effect of variant 259Thr on the kinase activity of RIP2.
In this study, an association was found between a
promoter SNP of the RIP2 gene and the most severe
cases of childhood atopic asthma . Regarding the
TLR4 gene, the Asp299Gly variant is associated with
hyporesponsiveness to inhaled endotoxin challenge,
reduced density of TLR4 in airway epithelium, and re-
duced production of inflammatory cytokines in re-
sponse to endotoxin.25 Yang et al.17 found that the
atopy severity score (based on the size and number
of positive skin-prick tests and specific IgE ) was
higher in subjects with allele 299Gly than in those
without allele 299Gly. RIP2-deficient mice were com-
pletely resistant to a lethal dose of lipopolysaccharide
(LPS),and macrophages from those mice showed im-
paired NF-κB and p 38 mitogen-activated protein
kinase (MAPK) activation and reduced cytokine pro-
duction in response to LPS stimulation.20 Lu et al.26
demonstrated that upon LPS stimulation, RIP2 is tran-
siently recruited to the TLR4 receptor complex and
associates with interleukin-1 receptor-associated
kinase (IRAK) 1 and TNF receptor-associated factor
(TRAF) 6. They also found that RIP2 kinase activity is
transiently induced by LPS treatment.26 While RIP2
functions as an adaptor molecule in LPS signaling, it
is possible that the polymorphisms of RIP2 involved
in asthma severity affect TLR4 signaling．
Furthermore , RIP 2 mediates cytokine-induced
IFN-γ production in Th1 and NK cells.20 IFN-γ has di-
verse immunoregulatory effects on various cells and
exerts an inhibitory effect on Th2 cells. Patients with
severe asthma have significantly reduced IFN-γ pro-
duction in response to house dust mite allergen rela-
tive to control subjects or subjects with resolved
asthma.27 Furthermore, there is reduced production
of IFN-γ by T cells in asthma subjects and this corre-
lates with the disease severity.28 Leung et al. 29 re-
ported reduced IFN-γ in corticosteroid resistant pa-
tients. Given the role of RIP2, genetic variants in RIP2
might contribute to asthma severity by affecting
IFNγ．
We did not analyze the functional effects of the pro-
moter polymorphisms found in this study, and the
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polymorphisms SNP12, 16, 17, 18, 19, 24, 26, and 27,
that were in linkage disequilibrium with the promoter
variant , were not examined either . Recent reports
have shown a significant association between pro-
moter and intronic polymorphisms of a gene and a
disease.30,31 Clarifying the alterations of gene func-
tions as the result of polymorphisms is necessary to
further validate the involvement of the RIP2 gene in
the pathogenesis of asthma．
Although we could not find any association be-
tween polymorphisms in RIP2 and the development
of asthma, further studies on other molecules in the
TLR signaling pathway are needed to clarify the
pathogenesis of asthma.
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